Pharmacokinetics and Safety of M107 Orally Disintegrating Tablet in Healthy Adults
Clinical trial NCT07056517 · COMPLETED
Trial details
- NCT number
- NCT07056517
- Sponsor
- Aclipse Two Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-11
- Primary completion
- 2025-09-22
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.